التفاصيل البيبلوغرافية
| العنوان: |
Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor. |
| المؤلفون: |
Sun, Hui, Zhang, XianJun, Zhao, Lei, Zhen, Xi, Huang, ShanYing, Wang, ShaSha, He, Hong, Liu, ZiMo, Xu, NaNa, Yang, FaLin, Qu, ZhongHua, Ma, ZhiYong, Zhang, Cheng, Zhang, Yun, Hu, Qin |
| المصدر: |
Journal of Cellular & Molecular Medicine; Apr2015, Vol. 19 Issue 4, p836-849, 14p |
| مصطلحات موضوعية: |
GENETICS of diabetes, ATHEROSCLEROSIS, APOLIPOPROTEIN E, GENE silencing, MACROPHAGES, CELL migration, RNA interference, LABORATORY mice |
| مستخلص: |
Macrophage migration inhibitory factor ( MIF) involves the pathogenesis of atherosclerosis ( AS) and increased plasma MIF levels in diabetes mellitus ( DM) patients are associated with AS. Here, we have been suggested that MIF could be a critical contributor for the pathological process of diabetes-associated AS by using adenovirus-mediated RNA interference. First, streptozotocin ( STZ)-induced diabetic animal model was constructed in 114 apolipoprotein E-deficient mice (apoE−/− mice) fed on a regular chow diet. Then, the animals were randomly divided into three groups: Adenovirus-mediated MIF interference (Ad- MIFi), Ad-enhanced green fluorescent protein ( EGFP) and normal saline ( NS) group ( n ≈ 33/group). Non-diabetic apoE−/− mice ( n = 35) were served as controls. Ad- MIFi, Ad- EGFP and NS were, respectively, injected into the tail vein of mice from Ad- MIFi, Ad- EGFP and NS group, which were injected repeatedly 4 weeks later. Physical, biochemical, morphological and molecular parameters were measured. The results showed that diabetic apoE−/− mice had significantly aggravated atherosclerotic lesions. MIF gene interference attenuated atherosclerotic lesions and stabilized atheromatous plaque, accompanied by the decreased macrophages and lipids deposition and inflammatory cytokines production, improved glucose intolerance and plasma cholesterol level, the decreased ratio of matrix matalloproteinase-2/tissue inhibitor of metalloproteinase-1 and plaque instability index. An increased expression of MIF and its ligand CD74 was also detected in the diabetic patients with coronary artery disease. The results suggest that MIF gene interference is able to inhibit atherosclerotic lesions and increase plaque stability in diabetic apoE−/−mice. MIF inhibition could be a novel and promising approach to the treatment of DM-associated AS. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Cellular & Molecular Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder